Potassium Aminobenzoate.

Potassium aminobenzoate is delivered as a potassium salt, so it contributes potassium alongside any separate potassium ingredient. The two amounts add up and should be counted together when total potassium in a formula is assessed.

Both ingredients deliver potassium ions, so their contributions sum in the same formula. This is a quantity interaction rather than a benefit, and the combined potassium figure is what matters.

Potassium citrate and potassium aminobenzoate both carry potassium as the counter-ion, so the potassium in a formula is the sum of the two. Citrate additionally contributes an alkalinising anion, which aminobenzoate does not.

Both are potassium salts, so their potassium contributions add together in a single serving. The bicarbonate portion is a separate buffering role that aminobenzoate has no part in.

Magnesium is required for normal function of the renal outer medullary potassium channel, and low magnesium drives renal potassium wasting. That means potassium supplementation works against a moving target when magnesium status is poor. The relationship is textbook electrolyte physiology and it runs in the other direction as well.

Sodium is the dominant extracellular cation and potassium the dominant intracellular one, and the Na/K-ATPase pump maintains the gradient between them. Total intake of each shapes how the body handles the other, particularly at the kidney. Any potassium salt contributes to that balance regardless of what the accompanying anion does.

Potassium aminobenzoate is a potassium salt, so every gram contributes elemental potassium on top of whatever an electrolyte blend supplies. Total daily potassium from all sources is the number that matters, not the count of products. Anyone with reduced kidney function or taking potassium-sparing medication should have that total reviewed by a clinician.

Calcium and potassium both influence membrane excitability in cardiac and skeletal muscle, and both are handled by renal tubular transport. They are not direct competitors for absorption. The pairing matters as part of a whole-electrolyte picture rather than as a single interaction.

Bacteria build folate from para-aminobenzoate using dihydropteroate synthase, an enzyme humans do not have. Humans must take folate ready-made, so aminobenzoate cannot substitute for dietary folate at any dose. Stating this straight is more useful than the older habit of listing aminobenzoate among the B vitamins.

Folate supports normal one-carbon metabolism in humans and must come from the diet. Aminobenzoate is only the ring precursor microbes use to assemble the folate molecule. A product carrying aminobenzoate does not thereby carry folate activity.

Some colonic bacteria, including several bifidobacteria, make folate de novo and use para-aminobenzoate as the ring precursor. Whether supplemental aminobenzoate reaches the colon in useful amounts and whether colonic folate is absorbed in meaningful quantity are both unsettled. Read this as mechanistic plausibility at low confidence, not as an established route.

Para-aminobenzoate was once packaged alongside the B vitamins and still appears in some B-complex products. Unlike pantothenic acid it is not a human vitamin and has no established human deficiency state. The pairing is a formulation habit rather than a biochemical relationship.

Both products deliver a cation with a base-forming anion, so the combination shifts total alkali and cation intake more than either alone. Gastric tolerance also falls when two salts are taken together on an empty stomach. Splitting doses across meals is the usual practical answer.

Ascorbic acid and gram-level salt doses both irritate the gastric lining in some people. Taking them together on an empty stomach raises that likelihood without any biochemical interaction between the two. This is a tolerability note about dosing, not a chemistry finding.